Cited by 483Antimicrobial Resistance in StaphylococcusAntibiotic Resistance in BacteriaAntibiotic Use and Resistance

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006

Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J., Hageman, J. C.·2008·Clinical Infectious Diseases

DOI 10.1086/527392

Open this paper in CoChat — free account

Abstract

BACKGROUND: This report compares the clinical characteristics, epidemiologic investigations, infection-control evaluations, and microbiologic findings of all 7 of the cases of vancomycin-resistant Staphylococcus aureus (VRSA) infection in the United States during the period 2002-2006. METHODS: Epidemiologic, clinical, and infection-control information was collected. VRSA isolates underwent confirmatory identification, antimicrobial susceptibility testing, pulsed-field gel electrophoresis, and typing of the resistance genes. To assess VRSA transmission, case patients and their contacts were screened for VRSA carriage. RESULTS: Seven cases were identified from 2002 through 2006; 5 were reported from Michigan, 1 was reported from Pennsylvania, and 1 was reported from New York. All VRSA isolates were vanA positive and had a median vancomycin minimum inhibitory concentration of 512 microg/mL. All case patients had a history of prior methicillin-resistant S. aureus and enterococcal infection or colonization; all had several underlying conditions, including chronic skin ulcers; and most had received vancomycin therapy prior to their VRSA infection. Person-to-person transmission of VRSA was not identified beyond any of the case patients. Infection-control precautions were evaluated and were consistent with established guidelines. CONCLUSIONS: Seven patients with vanA-positive VRSA have been identified in the United States. Prompt detection by microbiology laboratories and adherence to recommended infection control measures for multidrug-resistant organisms appear to have prevented transmission to other patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1086/527392

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,435
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,466
Mayo Clinic Proceedings
Rao, S. V., & Jollis, J. G. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.10.991 · Cited by 2,243
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Pulsed-Field Gel Electrophoresis Typing of Oxacillin-ResistantStaphylococcus aureusIsolates from the United States: Establishing a National Database
McDougal, L. K., Steward, C. D., Killgore, G., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,410
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Self-citation
Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90528-v · Cited by 935
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 909
Novel Type of Staphylococcal Cassette Chromosome mec Identified in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains
Ma, X. X., Ito, T., Tiensasitorn, C., Jamklang, M., Chongtrakool, P., Boyle-Vavra, S., Daum, R. S., & Hiramatsu, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1147-1152.2002 · Cited by 587

Show all 33 references

Research works printed but not linked: 7

WENZEL, 1982, Annals of Internal Medicine, 97, 440, 10.1059/0003-4819-97-3-440 · DOI
WATANAKUNAKORN, 1982, Annals of Internal Medicine, 97, 376, 10.1059/0003-4819-97-3-376 · DOI
Noble, 1992, FEMS Microbiology Letters, 72, 195, 10.1111/j.1574-6968.1992.tb05089.x · DOI
1997, MMWR. Morbidity and mortality weekly report, 46, 624
2004, MMWR. Morbidity and mortality weekly report, 53, 322
2007, MMWR. Morbidity and mortality weekly report, 56, 197
SARAVOLATZ, 1982, Annals of Internal Medicine, 97, 325, 10.1059/0003-4819-97-3-325 · DOI

Sorted by citations

Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Methicillin-resistant Staphylococcus aureus
Lee, A. S., de LENCASTRE, H., Garau, J., Kluytmans, J. A. J. W., Malhotra‐Kumar, S., Peschel, A., & Harbarth, S. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.33 · Cited by 1,691
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 934
Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence
Christaki, E., Marcou, M., & Tofarides, A. G. (2019) · Journal of Molecular Evolution · doi:10.1007/s00239-019-09914-3 · Cited by 875
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 816
The role of environmental cleaning in the control of hospital-acquired infection
Dancer, S. J. (2009) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.03.030 · Cited by 588
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features
Cong, Y., Yang, S., & Rao, X. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2019.10.005 · Cited by 571
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
DeLeo, F. R., & Chambers, H. F. “. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38226 · Cited by 522
New epidemiology of Staphylococcus aureus infection in Asia
Chen, C., & Huang, Y. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12705 · Cited by 461
Mechanisms of antibiotic resistance
Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421
Infections caused by Gram-positive bacteria: a review of the global challenge
Woodford, N., & Livermore, D. M. (2009) · Journal of Infection · doi:10.1016/s0163-4453(09)60003-7 · Cited by 418
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria
Medina, E., & Pieper, D. H. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_492 · Cited by 376
Prevention and Treatment of Cancer-Related Infections
Baden, L. R., Bensinger, W., Angarone, M., Casper, C., Dubberke, E. R., Freifeld, A. G., Garzon, R., Greene, J. N., Greer, J. P., Ito, J. I., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0146 · Cited by 366
Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
Prokocimer, P., Anda, C. S. D., Fang, E., Mehra, P., & Das, A. (2013) · JAMA · doi:10.1001/jama.2013.241 · Cited by 362
VanA-Type Vancomycin-ResistantStaphylococcus aureus
Périchon, B., & Courvalin, P. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00346-09 · Cited by 337
Horizontal gene transfer and the genomics of enterococcal antibiotic resistance
Palmer, K. L., Kos, V. N., & Gilmore, M. S. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.08.004 · Cited by 307
Envelope Structures of Gram-Positive Bacteria
Rajagopal, M., & Walker, S. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_5021 · Cited by 318
New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance
Gould, I. M., David, M. Z., Esposito, S., Garau, J., Lina, G., Mazzei, T., & Peters, G. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.028 · Cited by 303
Mechanism of antibacterial resistance, strategies and next-generation antimicrobials to contain antimicrobial resistance: a review
Belay, W. Y., Getachew, M., Tegegne, B. A., Teffera, Z. H., Dagne, A., Zeleke, T. K., Abebe, R. B., Gedif, A. A., Fenta, A., Yirdaw, G., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1444781 · Cited by 298
Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-Analysis
Svetitsky, S., Leibovici, L., & Paul, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00341-09 · Cited by 276
Increasing Antibiotic Resistance among Methicillin‐ResistantStaphylococcus aureusStrains
Sakoulas, G., & Moellering, R. C. (2008) · Clinical Infectious Diseases · doi:10.1086/533592 · Cited by 273
Developments in Glycopeptide Antibiotics
Blaskovich, M. A. T., Hansford, K. A., Butler, M. S., Jia, Z., Mark, A. E., & Cooper, M. A. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00258 · Cited by 270
The skin microbiome: Current perspectives and future challenges
Chen, Y. E., & Tsao, H. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.01.016 · Cited by 275
Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection
Corey, G. R., Wilcox, M. H., Talbot, G. H., Friedland, H. D., Baculik, T., Witherell, G. W., Critchley, I. A., Das, A., & Thye, D. A. (2010) · Clinical Infectious Diseases · doi:10.1086/655827 · Cited by 235
Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?
Cattoir, V., & Leclercq, R. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks469 · Cited by 241
Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells
Conlon, B. P. (2014) · BioEssays · doi:10.1002/bies.201400080 · Cited by 224
Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review
Kumar, M., Sarma, D. K., Shubham, S., Kumawat, M., Verma, V., Nina, P. B., Devraj, J. P., Kumar, S., Singh, B., & Tiwari, R. R. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.609459 · Cited by 234
Daptomycin Versus Vancomycin for Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus With a High Vancomycin Minimum Inhibitory Concentration: A Case-Control Study
Moore, C. L., Osaki-Kiyan, P., Haque, N. Z., Perri, M. B., Donabedian, S. M., & Zervos, M. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir764 · Cited by 220
Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance
Willems, R. J. L., Hanage, W. P., Bessen, D. E., & Feil, E. J. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00284.x · Cited by 207
Antibiotic Resistance by Enzymatic Modification of Antibiotic Targets
Schaenzer, A. J., & Wright, G. D. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.05.001 · Cited by 198
Staphylococcus aureus (Including Staphylococcal Toxic Shock)
Que, Y., & Moreillon, P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00195-8 · Cited by 177
Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus
Nannini, E. C., Murray, B. E., & Arias, C. A. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.06.006 · Cited by 170
Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis
Pancholi, P., Carroll, K. C., Buchan, B. W., Chan, R. C., Dhiman, N., Ford, B. A., Granato, P. A., Harrington, A., Hernandez, D. R., Humphries, R. M., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01329-17 · Cited by 168
Peptide pheromone signaling inStreptococcusandEnterococcus
Cook, L. C., & Federle, M. J. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12046 · Cited by 162
Worldwide Epidemiology and Antibiotic Resistance of Staphylococcus aureus
Monaco, M., de Araujo, F. P., Cruciani, M., Coccia, E. M., & Pantosti, A. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_3 · Cited by 174
Genetic Characterization of a Vancomycin-Resistant Staphylococcus aureus Isolate from the Respiratory Tract of a Patient in a University Hospital in Northeastern Iran
Azimian, A., Havaei, S. A., Fazeli, H., Naderi, M., Ghazvini, K., Samiee, S. M., Soleimani, M., & Peerayeh, S. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01727-12 · Cited by 157
Ceftaroline
Zhanel, G. G., Sniezek, G., Schweizer, F., Zelenitsky, S. A., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Hoban, D. J., & Karlowsky, J. A. (2009) · Drugs · doi:10.2165/00003495-200969070-00003 · Cited by 151
Comparative Genomics of Vancomycin-Resistant Staphylococcus aureus Strains and Their Positions within the Clade Most Commonly Associated with Methicillin-Resistant S. aureus Hospital-Acquired Infection in the United States
Kos, V. N., Desjardins, C. A., Griggs, A. D., Cerqueira, G., van Tonder, A. J., Holden, M. T. G., Godfrey, P. A., Palmer, K. L., Bodi, K. L., Mongodin, E. F., et al. (2012) · mBio · doi:10.1128/mbio.00112-12 · Cited by 153
Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections
Eleftheriadou, I., Tentolouris, N., Argiana, V., Jude, E. B., & Boulton, A. J. M. (2010) · Drugs · doi:10.2165/11538070-000000000-00000 · Cited by 150
Vancomycin-Resistant Staphylococcus aureus Isolates Associated with Inc18-Like vanA Plasmids in Michigan
Zhu, W., Clark, N. C., McDougal, L. K., Hageman, J. C., McDonald, L. C., & Patel, J. B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00908-07 · Cited by 148
Self-citation
Mobile genetic elements of the human gastrointestinal tract
Broaders, E., Gahan, C. G. M., & Marchesi, J. R. (2013) · Gut Microbes · doi:10.4161/gmic.24627 · Cited by 151
Staphylococcus aureus: Overview of Bacteriology, Clinical Diseases, Epidemiology, Antibiotic Resistance and Therapeutic Approach
Gnanamani, A., Periasamy, H., & Satyaseela, M. P. (2017) · InTech eBooks · doi:10.5772/67338 · Cited by 141
Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci
Leclercq, R. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02739.x · Cited by 140
Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time
Knight, G. M., Budd, E. L., Whitney, L., Thornley, A., Al-Ghusein, H., Planche, T., & Lindsay, J. A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks245 · Cited by 143
Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin
Smith, K., Perez, A., Ramage, G., Gemmell, C. G., & Lang, S. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.08.029 · Cited by 137
Evolving Resistance Among Gram-positive Pathogens
Munita, J. M., Bayer, A. S., & Arias, C. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ523 · Cited by 138
What is MRSA?
Pantosti, A., & Venditti, M. (2009) · European Respiratory Journal · doi:10.1183/09031936.00007709 · Cited by 134
Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions
Moise, P. A., North, D. S., Steenbergen, J. N., & Sakoulas, G. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70200-2 · Cited by 127
Report of the 13th Vancomycin-Resistant Staphylococcus aureus Isolate from the United States
Limbago, B. M., Kallen, A. J., Zhu, W., Eggers, P. C., McDougal, L. K., & Albrecht, V. S. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02187-13 · Cited by 124
Community-Associated Methicillin-Resistant Staphylococcus aureus: An Enemy amidst Us
Kong, E. F., Johnson, J. K., & Jabra‐Rizk, M. A. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005837 · Cited by 122
Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci
Foucault, M.-L., Depardieu, F., Courvalin, P. M., & Grillot‐Courvalin, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006855107 · Cited by 121
Staphylococcus aureus Infections in Hemodialysis
Vandecasteele, S. J., Boelaert, J. R., & Vriese, A. S. D. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01590309 · Cited by 118
Regulation of antibiotic resistance in Staphylococcus aureus
Holmes, N., Berger‐Bächi, B., & Senn, M. M. (2009) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.08.015 · Cited by 113
Defects in Innate Immunity Predispose C57BL/6J-Leprdb/LeprdbMice to Infection byStaphylococcus aureus
Park, S., Rich, J., Hanses, F., & Lee, J. C. (2008) · Infection and Immunity · doi:10.1128/iai.00976-08 · Cited by 111
Structural Insights into the Anti-methicillin-resistant Staphylococcus aureus (MRSA) Activity of Ceftobiprole
Lovering, A. L., Gretes, M. C., Safadi, S. S., Danel, F., de Castro, L., Page, M. G. P., & Strynadka, N. C. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355644 · Cited by 109
Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus to Newer Antimicrobial Agents
Watkins, R., Holubar, M. K., & David, M. Z. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01216-19 · Cited by 108
Structure-based mechanism of lipoteichoic acid synthesis by Staphylococcus aureus LtaS
Lü, D., Wörmann, M. E., Zhang, X., Schneewind, O., Gründling, A., & Freemont, P. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809020106 · Cited by 106
Secular Trends of Hospitalization With Vancomycin-Resistant Enterococcus Infection in the United States, 2000–2006
Ramsey, A. M., & Zilberberg, M. D. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/593956 · Cited by 106
New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus
Assis, L. M., Nedeljković, M., & Dessen, A. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.03.001 · Cited by 104
Detection of vancomycin-resistant enterococci (VRE) at four U.S. wastewater treatment plants that provide effluent for reuse
Goldstein, R. E. R., Micallef, S. A., Gibbs, S. G., George, A., Claye, E., Sapkota, A. R., Joseph, S. W., & Sapkota, A. R. (2013) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2013.07.039 · Cited by 102
Clinical impact of antibiotic-resistant Gram-positive pathogens
Lode, H. M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02738.x · Cited by 102
Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections
Smith, J. R., Roberts, K. D., & Rybak, M. J. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0077-7 · Cited by 101
β-Lactam and glycopeptide antibiotics: first and last line of defense?
Jovetic, S., Zhu, Y., Marcone, G. L., Marinelli, F., & TRAMPER, J. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.09.004 · Cited by 104
Potentials of nanotechnology in treatment of methicillin-resistant Staphylococcus aureus
Gao, Y., Chen, Y., Cao, Y., Mo, A., & Peng, Q. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113056 · Cited by 101
Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance
Karlowsky, J. A., Nichol, K. A., & Zhanel, G. G. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ534 · Cited by 98
Nine-Hospital Study Comparing Broth Microdilution and Etest Method Results for Vancomycin and Daptomycin against Methicillin-Resistant Staphylococcus aureus
Sader, H. S., Rhomberg, P. R., & Jones, R. N. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00093-09 · Cited by 97
RETRACTED ARTICLE: Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates
Wu, Q., Sabokroo, N., Wang, Y., Hashemian, M., Karamollahi, S., & Kouhsari, E. (2021) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-021-00967-y · Cited by 99
Retracted
Staphylococcus aureus FabI: Inhibition, Substrate Recognition, and Potential Implications for In Vivo Essentiality
Schiebel, J., Chang, A. T., Lu, H., Baxter, M. V., Tonge, P. J., & Kisker, C. (2012) · Structure · doi:10.1016/j.str.2012.03.013 · Cited by 96
Methicillin-Resistant Staphylococcus aureus Infection and Treatment Options
Chalmers, S. J., & Wylam, M. E. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9849-4_16 · Cited by 93
Management of methicillin-resistant Staphylococcus aureus infections
Garau, J., Bouza, E., Chastre, J. E., Gudiol, F., & Harbarth, S. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02701.x · Cited by 91
Antibiotics and bioactive natural products in treatment of methicillin resistant Staphylococcus aureus: A brief review
Kali, A. (2015) · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · doi:10.4103/0973-7847.156329 · Cited by 91
Improved photodynamic inactivation of gram‐positive bacteria using hematoporphyrin encapsulated in liposomes and micelles
Tsai, T., Yang, Y., Wang, T., Chien, H., & Chen, C. (2009) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20754 · Cited by 91
Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022
van Groesen, E., Innocenti, P., & Martin, N. I. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00253 · Cited by 89
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare
Calfee, D. P. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283553441 · Cited by 87
Clinical, Epidemiological, and Laboratory Aspects of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections
Palavecino, E. L. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-468-1_1 · Cited by 88
Antibacterial photodynamic therapy using water-soluble formulations of hypericin or mTHPC is effective in inactivation of Staphylococcus aureus
Engelhardt, V., Krammer, B. E., & Plaetzer, K. (2010) · Photochemical & Photobiological Sciences · doi:10.1039/b9pp00144a · Cited by 86
Vancomycin-ResistantStaphylococcus aureus,Michigan, USA, 2007
Finks, J. L., Wells, E. V., Dyke, T. L., Husain, N., Plizga, L. A., Heddurshetti, R., Wilkins, M. J., Rudrik, J. T., Hageman, J. C., Patel, J. B., et al. (2009) · Emerging infectious diseases · doi:10.3201/eid1506.081312 · Cited by 86
Self-citation
Comparative Genomics and Transduction Potential of Enterococcus faecalis Temperate Bacteriophages
Yasmin, A., Kenny, J. G., Shankar, J., Darby, A. C., Hall, N., Edwards, C., & Horsburgh, M. J. (2009) · Journal of Bacteriology · doi:10.1128/jb.01293-09 · Cited by 91
Are We Ready for Novel Detection Methods to Treat Respiratory Pathogens in Hospital-Acquired Pneumonia?
Endimiani, A., Hujer, K. M., Hujer, A. M., Kurz, S. G., Jacobs, M. R., Perlin, D. S., & Bonomo, R. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir054 · Cited by 82
Staphylococcus aureus:Methicillin‐SusceptibleS. aureusto Methicillin‐ResistantS. aureusand Vancomycin‐ResistantS. aureus
Rehm, S. J., & Tice, A. D. (2010) · Clinical Infectious Diseases · doi:10.1086/653518 · Cited by 84
Acquired Vancomycin Resistance in Clinically Relevant Pathogens
Werner, G., Strommenger, B., & Witte, W. (2008) · Future Microbiology · doi:10.2217/17460913.3.5.547 · Cited by 84
Development of Reduced Vancomycin Susceptibility in Methicillin‐Susceptible Staphylococcus aureus
Pillai, S. K., Wennersten, C. B., Venkataraman, L., Eliopoulos, G. M., Moellering, R. C., & Karchmer, A. W. (2009) · Clinical Infectious Diseases · doi:10.1086/605636 · Cited by 82
Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: A three year study in Tehran, Iran
Shekarabi, M., Hajikhani, B., Chirani, A. S., Fazeli, M., & Goudarzi, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183607 · Cited by 83
An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy
Watkins, R., Lemonovich, & File, T. M. (2012) · Core evidence · doi:10.2147/ce.s33430 · Cited by 86
Vancomycin promotes the bacterial autolysis, release of extracellular DNA, and biofilm formation in vancomycin-non-susceptible Staphylococcus aureus
Hsu, C.-Y., Lin, M., Chen, C., Chien, S.-C., Cheng, Y.-H., Su, I.-N., & Shu, J. (2011) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2011.00846.x · Cited by 81
Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Bloodstream Isolates in Urban Detroit
Chua, T., Moore, C. L., Perri, M. B., Donabedian, S. M., Masch, W. R., Vager, D. L., Davis, S. L., Lulek, K., Zimnicki, B., & Zervos, M. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00154-08 · Cited by 81
Antimicrobial peptide-modified liposomes for bacteria targeted delivery of temoporfin in photodynamic antimicrobial chemotherapy
Yang, K., Gitter, B., Rüger, R., Wieland, G. D., Chen, M., Liu, X., Albrecht, V., & Fahr, A. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05100h · Cited by 77
Mechanisms of antimicrobial resistance among hospital-associated pathogens
Khan, A., Miller, W. R., & Arias, C. A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1456919 · Cited by 82
pSK41-Like Plasmid Is Necessary for Inc18-Like vanA Plasmid Transfer from Enterococcus faecalis to Staphylococcus aureus In Vitro
Zhu, W., Clark, N. C., & Patel, J. B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01587-12 · Cited by 76
Self-citation
Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA)
Duplessis, C. A., & Crum‐Cianflone, N. F. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s1637 · Cited by 83
The Changing Face of Staphylococcus aureus: A Continuing Surgical Challenge
Fry, D. E., & Barie, P. S. (2011) · Surgical Infections · doi:10.1089/sur.2011.068 · Cited by 73
National Burden of Invasive Methicillin-ResistantStaphylococcus aureusInfection
Malani, P. (2014) · JAMA · doi:10.1001/jama.2014.1666 · Cited by 73
Human-to-Bovine Jump of Staphylococcus aureus CC8 Is Associated with the Loss of a β-Hemolysin Converting Prophage and the Acquisition of a New Staphylococcal Cassette Chromosome
Resch, G., François, P., Morisset, D., Stojanov, M., Bonetti, E.-J., Schrenzel, J., Sakwińska, O., & Moreillon, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058187 · Cited by 73
Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005
Zilberberg, M. D., Shorr, A. F., & Kollef, M. H. (2008) · Emerging infectious diseases · doi:10.3201/eid1411.080337 · Cited by 71
Bacterial evolution during human infection: Adapt and live or adapt and die
Culyba, M. J., & Tyne, D. V. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009872 · Cited by 71
Surveillance and management of multidrug-resistant microorganisms
Orsi, G. B., Falcone, M., & Venditti, M. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.77 · Cited by 69
Health Care–Associated Infection (HAI): A Critical Appraisal of the Emerging Threat—Proceedings of the HAI Summit
Kollef, M. H., Napolitano, L. M., Solomkin, J. S., Wunderink, R. G., Bae, I., Fowler, V. G., BALK, R. A., Stevens, D. L., Rahal, J. J., Shorr, A. F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590937 · Cited by 70

Authors: Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J., & Hageman, J. C.
Affiliations: Centers for Disease Control and Prevention (US)
Michigan Department of Health and Human Services (US)
Corresponding author: Sievert, D. M.
ORCID: Patel, J. B.
McDonald, L. C.
Wilkins, M. J.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2008-03-01
Volume: 46
Issue: 5
Pages: 668-674
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1086/527392
OpenAlex: W2023638940
Cited by: 483
References: 33
Citations by year: 2026: 7 · 2025: 9 · 2024: 7 · 2023: 16 · 2022: 14 · 2021: 15 · 2020: 16 · 2019: 21 · 2018: 25 · 2017: 20 · 2016: 19 · 2015: 27 · 2014: 39 · 2013: 36 · 2012: 37
FWCI: 37.07
Type: journal article
Language: en
Open access: closed
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords: vancomycin-resistant Staphylococcus aureus, vanA gene, methicillin-resistant Staphylococcus aureus, enterococcal infections, human-to-human transmission, infection control, multidrug-resistant organisms, antimicrobial resistance, chronic skin ulcers, United States
MeSH terms: Adult, Aged, Bacterial Proteins, Carrier State, DNA, Bacterial, Family Health, Female, Genotype, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, United States, Bacterial Typing Techniques, Electrophoresis, Gel, Pulsed-Field, Infection Control, Carbon-Oxygen Ligases, Guideline Adherence, Vancomycin Resistance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks